We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » THREE WARNINGS ISSUED TO TRIAL INVESTIGATORS
THREE WARNINGS ISSUED TO TRIAL INVESTIGATORS
August 13, 2004
Continuing a recent enforcement trend, the FDA last week published three new warning letters addressed to clinical trial operators.
The agency has issued a plethora of warnings to clinical investigators in recent months as part of an effort to crackdown on violations at universities and other research sites.